Nu Skin Enterprises, Inc.
NUS
$8.48
-$0.09-1.05%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 370.32M | 364.21M | 386.14M | 364.49M | 445.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 370.32M | 364.21M | 386.14M | 364.49M | 445.55M |
| Cost of Revenue | 108.34M | 107.49M | 120.41M | 117.53M | 127.61M |
| Gross Profit | 261.98M | 256.72M | 265.73M | 246.96M | 317.95M |
| SG&A Expenses | 238.74M | 235.08M | 234.95M | 231.75M | 286.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 347.08M | 342.57M | 355.36M | 349.28M | 413.96M |
| Operating Income | 23.24M | 21.64M | 30.78M | 15.21M | 31.60M |
| Income Before Tax | 18.19M | 15.99M | 27.41M | 134.60M | -57.80M |
| Income Tax Expenses | 3.70M | -1.09M | 6.29M | 27.09M | -21.70M |
| Earnings from Continuing Operations | 14.49M | 17.08M | 21.12M | 107.52M | -36.11M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.49M | 17.08M | 21.12M | 107.52M | -36.11M |
| EBIT | 23.24M | 21.64M | 30.78M | 15.21M | 31.60M |
| EBITDA | 36.16M | 33.73M | 43.83M | 29.42M | 48.04M |
| EPS Basic | 0.30 | 0.35 | 0.43 | 2.16 | -0.73 |
| Normalized Basic EPS | -0.13 | 0.56 | 0.70 | 0.15 | 0.34 |
| EPS Diluted | 0.28 | 0.34 | 0.43 | 2.14 | -0.73 |
| Normalized Diluted EPS | -0.12 | 0.55 | 0.70 | 0.14 | 0.34 |
| Average Basic Shares Outstanding | 48.58M | 49.40M | 49.44M | 49.76M | 49.71M |
| Average Diluted Shares Outstanding | 49.91M | 50.31M | 49.50M | 50.33M | 49.71M |
| Dividend Per Share | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Payout Ratio | 20.05% | 17.34% | 14.03% | 2.79% | -8.26% |